Management of Hypercalciuria with Medullary Nephrocalcinosis and Renal Stone

Diagnostic Evaluation

Additional metabolic testing should be performed to identify specific risk factors that can guide targeted therapy 1
Complete metabolic evaluation should include one or two 24-hour urine collections analyzed for total volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine 2
Serum intact parathyroid hormone level should be checked if primary hyperparathyroidism is suspected, especially with high or high-normal serum calcium 1
Stone analysis should be performed if available to determine composition and guide therapy 1

Patients should increase fluid intake to achieve urine volume of at least 2.5 liters daily, which is critical for reducing concentration of lithogenic factors 2, 3
Sodium intake should be limited to 2,300 mg (100 mEq) daily to reduce urinary calcium excretion 3, 4
Normal dietary calcium intake of 1,000-1,200 mg per day should be maintained, as dietary calcium restriction can paradoxically increase stone risk 3
Calcium should be consumed primarily with meals to bind dietary oxalate in the gut 4
Calcium supplements should be avoided, as they may increase stone risk unlike dietary calcium 3
Intake of oxalate-rich foods should be limited if urinary oxalate is elevated 4

Thiazide diuretics are the first-line pharmacological therapy for patients with hypercalciuria and recurrent calcium stones 5, 4
Potassium supplementation may be needed when using thiazides to prevent potassium wasting 4
Potassium citrate therapy should be added if urinary citrate is low or relatively low 4, 6

Follow-up 24-hour urine collections should be obtained to assess response to therapy and guide adjustments 1
Imaging studies should be performed periodically to monitor stone burden and nephrocalcinosis 1
Therapy should be continued indefinitely in patients with persistent risk factors, as discontinuation may lead to stone recurrence 6

Medullary nephrocalcinosis implies an underlying metabolic disorder that predisposes to stone formation 1

Sodium citrate preparations should be avoided in favor of potassium citrate, as sodium citrate may increase urinary calcium excretion and potentially promote stone formation 7
Lower doses of thiazides are associated with fewer adverse effects but may be less effective for stone prevention 5
Combination therapy with multiple agents has not been shown to be more beneficial than monotherapy for most patients 5
Patients should be monitored for side effects of thiazide therapy, including hypokalemia, hyperglycemia, and hyperlipidemia 5